TY  - JOUR

T1  - Abstract B61: Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors.

JO  - Molecular Cancer Therapeutics

UR  - https://doi.org/10.1158/1535-7163.targ-13-b61

PY  - 2013/11/01

AU  - Wang W-T

AU  - Catto J

AU  - Meuth M

ED  - 

DO  - DOI: 10.1158/1535-7163.targ-13-b61

PB  - American Association for Cancer Research (AACR)

VL  - 12

IS  - 11_Supplement

SP  - B61

EP  - B61

Y2  - 2025/10/31

ER  -